Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irsogladine Maleate for NSAID-Associated Small Intestinal Mucosal Injury
NCT05249725Phase 4Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Apr 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of irsogladine in Small intestinal mucosal injury, sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
irsogladine
03
Conditions
Small intestinal mucosal injury
Beyond the preview
Go deeper on NCT05249725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05249725.